Antipsychotic Agents: all 1,683 studies that test it
Page 10 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Comparison of the Effectiveness of Brexpiprazole With That of RisperidoneWithdrawnNCT02758067Phase 3
- IV Haloperidol for the Treatment of Headache in the EDCompletedNCT02747511Phase 4
- Prophylaxis of Postoperative Nausea and Vomiting After Cardiac SurgeryCompletedNCT02744495Phase 3
- Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar PatientsCompletedNCT02731612Phase 3
- A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month FormulationCompletedNCT02713282Phase 3
- Molecular Mechanisms of Antipsychotic-induced Insulin ResistanceCompletedNCT02708394Early Phase 1
- Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in SchCompletedNCT02697045Phase 4
- A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary HypertensionWithdrawnNCT02684786Phase 1
- Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaWithdrawnNCT02661347Not applicable
- Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol FormulationsCompletedNCT02660840Phase 1
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic TreatmentStatus unknownNCT02650102Phase 1/2
- Switching Antipsychotics: Abrupt Discontinuation Versus OverlapCompletedNCT02640300Phase 4
- A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT02636842Phase 1
- Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneCompletedNCT02634463Phase 1
- The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.CompletedNCT02625103Phase 4
- Quetiapine for Delirium Prophylaxis in High-risk Critically Ill PatientsCompletedNCT02612948Phase 4
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaCompletedNCT02593734Phase 4
- Combination Treatment for Augmenting Language in Children With ASDCompletedNCT02574741Phase 2
- Clozapine Versus Other Atypical Antipsychotics for Bipolar DisorderStatus unknownNCT02562287Phase 4
- Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward ImpulsivityCompletedNCT02557984Not applicable
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS DependenceStatus unknownNCT02541513Phase 3
- Nicotinic Receptors and SchizophreniaWithdrawnNCT02538081Phase 1/2
- Schizotypal Personality Disorder RisperidoneCompletedNCT02535156Phase 1/2
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upCompletedNCT02534363Phase 4
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upStatus unknownNCT02532491Phase 4
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upCompletedNCT02526030Phase 4
- Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy VolunteersCompletedNCT02501109Phase 1
- A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALSStatus unknownNCT02463825Phase 2
- Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar DisorderCompletedNCT02456454Phase 3
- Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With SchizophreniaStatus unknownNCT02453893Phase 3
- Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar DisorderStatus unknownNCT02451306Not applicable
- Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin ExtractionCompletedNCT02447835Phase 1
- 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset SchizophreniaCompletedNCT02435654Phase 4
- Antipsychotic Induced Structural and Functional Brain ChangesTerminatedNCT02435095Phase 4
- A Pharmacokinetic Study of Paliperidone ERStatus unknownNCT02433717Phase 4
- Baden Prevention and Reduction of Incidence of Postoperative Delirium TrialCompletedNCT02433041Phase 4
- A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic ChemotherapyStatus unknownNCT02400866Phase 2
- IM Olanzapine Versus Haloperidol or MidazolamTerminatedNCT02380118Phase 4
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Treatment of Hypoactive Delirium and Outcome MeasuresStatus unknownNCT02345902Phase 3
- Pan European Collaboration on Antipsychotic Naïve Schizophrenia IICompletedNCT02339844Phase 4
- An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaCompletedNCT02320032Phase 1
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisCompletedNCT02305823Phase 4
- Prophylactic Quetiapine on Delirium Prevention in Critically Ill PatientsStatus unknownNCT02297763Phase 3
- Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus PaclitaxelStatus unknownNCT02290470Phase 2
- Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)CompletedNCT02287259Phase 4
- Study of the Effect of Dosing on Clozapine LevelsWithdrawnNCT02286206Phase 4
- An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02186769Phase 1
- Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationCompletedNCT02184767Phase 1
- Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)CompletedNCT02179931Phase 1
- Neural Basis of Decision-Making Deficits in Traumatic Brain InjuryCompletedNCT02169310Phase 1
- Cariprazine: Comparison of Slow- and Immediate-release FormsCompletedNCT02165098Phase 1
- Lurasidone and Cognition in Bipolar I DisorderCompletedNCT02147379Phase 3
- European Long-acting Antipsychotics in Schizophrenia TrialCompletedNCT02146547Phase 4
- L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use DisorderWithdrawnNCT02139761Phase 2
- Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaCompletedNCT02137993Phase 4
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major DepressionCompletedNCT02132286Phase 4
- Pharmacokinetic Study Comparing Topical, Rectal, and Oral QuetiapineCompletedNCT02131545Phase 1
- Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With DeliriumWithdrawnNCT02118688Phase 4
- Ketamine Versus Haloperidol for Severe Agitation Outside the HospitalWithdrawnNCT02103881Phase 4
- Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCTWithdrawnNCT02098499Phase 4
- Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02096289Phase 1
- Association of Amisulpride Response in Schizophrenia With Brain ImageStatus unknownNCT02095938Phase 4
- Bioavailability of LY03004 and Risperdal® Consta®CompletedNCT02091388Phase 1
- Safety and Tolerability of Quetiapine in Multiple SclerosisCompletedNCT02087631Phase 1/2
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric ParticipantsCompletedNCT02087579Phase 1
- Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ERCompletedNCT02075528Phase 4
- Study to Evaluate the Efficacy and Safety of AripiprazoleStatus unknownNCT02069977Phase 4
- Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive DisordersTerminatedNCT02063945Phase 4
- Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02055287Phase 1
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyCompletedNCT02051387Phase 1
- The Effect of Sertindole and Risperidone on Endophenotypic Markers of SchizophreniaTerminatedNCT02021201Phase 4
- Adjunctive Aripiprazole in the Treatment of Risperidone-Induced HyperprolactinemiaStatus unknownNCT02013232Not applicable
- Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I DisorderWithdrawnNCT01981811Phase 2
- A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With LurasidoneCompletedNCT01979679Phase 3
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic EpisodeCompletedNCT01977300Phase 3
- Investigator Initiated Study - Asenapine Early PsychosisStatus unknownNCT01968161Phase 4
- Bio-equivalence Study Between SAPHRIS and AsenapineCompletedNCT01948024Phase 1
- A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With SchizophreniaCompletedNCT01947803Phase 4
- A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With SchizophreniaCompletedNCT01942382Phase 1
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsWithdrawnNCT01942187Phase 4
- Algorithm Guided Treatment Strategies for Bipolar DepressionStatus unknownNCT01938859Phase 4
- Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years OldWithdrawnNCT01932541Phase 4
- Oral Multiple-dose Study in Patients With Major Depressive DisorderCompletedNCT01924520Phase 1
- Brain Networks and Addiction SusceptibilityCompletedNCT01924468Phase 1
- Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive DisorderCompletedNCT01919008Phase 1
- Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male VolunteersCompletedNCT01908296Phase 1
- Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive DisorderCompletedNCT01903200Phase 1
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute ManiaStatus unknownNCT01893229Phase 4
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With PsychosisCompletedNCT01878513Not applicable
- Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy VolunteersCompletedNCT01871987Phase 1
- Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive DisorderCompletedNCT01871974Phase 1
- Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic DrugsCompletedNCT01871701Phase 1
- Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar DisorderCompletedNCT01864551Phase 4
- Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for DeliriumCompletedNCT01862302Phase 3
- The Effect of Paliperidone Palmitate in SchizophreniaCompletedNCT01860781Phase 4
- An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine DependenceCompletedNCT01825928Not applicable
- A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated PsychosisCompletedNCT01822730Phase 4